NeuroRestore.swiss

Defitech center for Interventional Neurotherapies - We develop new strategies involving neurosurgical interventions to restore neurological functions.

[ONWARD Medical @onwdempowered]

Have questions about the brain-computer interface (BCI) landscape? If so, read on for our take on the fast-moving BCI ecosystem and what sets us apart.

➡️ Unlike pure-play BCI companies focused on developing technology to help a paralyzed person communicate with a computer mouse, keyboard, or voice generator, we are advancing BCI technology to control our investigational implantable ARC-IM® spinal cord stimulation therapy that is designed to restore thought-driven movement of the human body after paralysis.

➡️ The BCI we are using in clinical feasibility studies pairs ARC-IM Therapy with a BCI from @CEA_Leti-CLINATEC with 5 years of human safety data.

➡️ While Neuralink is at an early clinical stage with its first human BCI implant, peer-reviewed publications have described how our ARC-IM Therapy restored movement of the legs, including the ability to walk, in 10 people with spinal cord injury and 2 with Parkinson’s disease, including one person who also received a BCI to enable more natural, thought-driven movement.

➡️ A second person has been implanted with ARC-IM Therapy plus a BCI in a study researching thought-driven movement of the arms and hands, and at least 3 additional ARC-IM + BCI implants are planned over the next year.

➡️ Our ARC-IM System is “BCI-ready” -- it has been designed to receive wireless signals from a BCI. That means we could eventually collaborate with Neuralink and other BCI companies.

To learn more about the unique ways in which ONWARD is researching BCI technology to help people regain movement after paralysis and to put recent BCI news in context, please watch the video interview below with CEO Dave Marver. ⬇️

*All ONWARD Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

#EmpoweringMovement #SCI #BCI #ONWARDJourneys

https://t.co/qXxIKKmwLA

[ONWARD Medical @onwdempowered]

Congratulations to our research partners, Professor Grégoire Courtine and Dr. Jocelyne Bloch and their team at @_NeuroRestore, for making the @nytimes list of “20 Things That Happened for the First Time in 2023.” The newspaper celebrated a “series of surprising and serious events and trends that were unprecedented until now.” The article highlights their milestone achievement documented in Nature earlier this year involving the use of a brain-computer interface (BCI) paired with our ARC Therapy™ to enable a man to walk with augmented control over his paralyzed legs. We are continuing our work around ARC Therapy and BCI and look forward to learning more about the potential of this groundbreaking technology. 🚀

Article here: https://t.co/IGld4rE3Aa

*All ONWARD therapies are investigational and not available for commercial use.

#EmpoweringMovement #SCI #NYTimes

[Wyss Center @Wysscenter]

🌟 We're thrilled to announce the launch of our groundbreaking project: Synapsuit - Translating arm and hand movement intentions into action. ✨💪

@NeurosoftBio , @_NeuroRestore #LighthousePartnership #stroke #spinalcordinjury #Neurotechnology #AI

More https://t.co/frq21HkBzg

[NeuroRestore.swiss @_NeuroRestore]

@8d4krnfvwzGreg @gcourtine @elonmusk @neuralink Why not?

[NeuroRestore.swiss @_NeuroRestore]

🧠⚡️🚶"Currently, @elonmusk has only implanted a chip in the brain. We have already linked our neurostimulation platform with (a brain-computer interface) device to restore movement after paralysis. We welcome the opportunity to do the same with the @neuralink device." @gcourtine @USATODAY

https://t.co/PmS218b9QA

[NeuroRestore.swiss @_NeuroRestore]

@neuralink joins the ranks developing thought-reading #BCI devices in human trials. 💪 Pairing them with our spinal cord stimulation tech could restore movement after paralysis. Let's bridge the brain-spinal cord gap @elonmusk ⚡️🫦

[EPFL @EPFL_en]

Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here’s a look at some of the promising new therapies they’ve developed. @epflSV @_NeuroRestore

https://t.co/kxwPKe1fyy

[NeuroRestore.swiss @_NeuroRestore]

We are thrilled to announce our latest breakthrough aimed at improving the mobility of those battling late-stage Parkinson’s disease.

A study published in @NatureMedicine: https://t.co/nFC7Vd9EFe

https://t.co/hDWFetkA9S

[NeuroRestore.swiss @_NeuroRestore]

Discover our latest study, published in @ScienceMagazine , which reveals a groundbreaking approach to regenerating axons through complete spinal cord injury, reversing paralysis.

Read the full article here: https://t.co/cPxitS2xl0

[ROLEX @ROLEX]

Grégoire Courtine and Jocelyne Bloch are developing new technology to restore lost movement in people with paralysis due to spinal cord injuries. Their implants detect brain signals and deliver them to the spinal cord. More on https://t.co/ryni4MncuJ #PerpetualPlanet #RolexAwards

[FENS @FENSorg]

Meet #FENS2024 Plenary Speaker Gregoire Courtine (CH)!

A groundbreaking #neuroscientist and pioneer in #bioengineering. His work at @_NeuroRestore has led to remarkable advancements in restoring #neurological functions.

More: https://t.co/pDNtGb1s1O
@gcourtine @EPFL_en

[NeuroRestore.swiss @_NeuroRestore]

We are extremely excited about the ways in which these atlases open new perspectives on the biology of SCI, which culminated in the development of a new therapeutic approach that rejuvenates the spinal cords of aged mice to restore the natural recovery of walking

[NeuroRestore.swiss @_NeuroRestore]

Thrilled to share our Tabulae Paralytica: snRNA-seq, multiome, 2D- and 3D spatial transcriptomic atlases of spinal cord injury 📷 @j_squair @gcourtine @skinniderlab

https://t.co/xyJppI0Oga

[NeuroRestore.swiss @_NeuroRestore]

Together, these four atlases include 482,825 single cells and 71,499 spatial barcodes from 18 different experimental conditions, all of which we overlaid onto a model of the injured spinal cord spanning four spatiotemporal dimensions

[NeuroRestore.swiss @_NeuroRestore]

Thrilled to share our Tabulae Paralytica: snRNA-seq, multiome, 2D- and 3D spatial transcriptomic atlases of spinal cord injury 📷

https://t.co/2DFUqqPyVu…

@j_squair @gcourtine @skinniderlab

[ROLEX @ROLEX]

Congratulations to #RolexAwards Laureate Grégoire Courtine and his team for their article published in @Nature about a wireless digital bridge that transforms thought into action and allows a paralyzed person to walk again. More on https://t.co/FgB8GKPjtM #PerpetualPlanet

[NeuroRestore.swiss @_NeuroRestore]

We are thrilled to share our new Nature article on Thought-Controlled Walking after a spinal cord injury! Powered by #BCI technology! We enabled an individual with a spinal cord injury to regain mobility through the power of his thoughts. https://t.co/T5e8Vo4cPY

[NeuroRestore.swiss @_NeuroRestore]

Congratulations to Jordan Squair for winning the BioInnovation Institute & Science Prize. Jordan leads a dedicated team at .NeuroRestore that focuses on improving the quality of life for patients by addressing impaired blood pressure management.

https://t.co/Y45mROnTCT

[NeuroRestore.swiss @_NeuroRestore]

For our French-speaking audience: 8min with our laboratory manager Quentin Barraud, PhD talking to a Swiss journalist about our latest publication in Nature "The neurons that restore walking after paralysis".

https://t.co/Yn5PLE3QND

[NeuroRestore.swiss @_NeuroRestore]

THE NEURONS THAT RESTORE WALKING AFTER PARALYSIS. Read our new publication in @Nature today! The mechanisms explaining the recovery of walking by 9 individuals with spinal cord injury in response to electrical spinal cord stimulation.

https://t.co/LctEAPlDvP